[Hopes and experiences in the treatment of severe pulmonary hypertension]

Rev Esp Cardiol. 2003 Mar;56(3):228-9. doi: 10.1016/s0300-8932(03)76857-2.
[Article in Spanish]
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Endothelin-1 / antagonists & inhibitors
  • Epoprostenol / therapeutic use
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Piperazines / therapeutic use
  • Purines
  • Sildenafil Citrate
  • Sulfones
  • Vasodilator Agents / therapeutic use

Substances

  • Antihypertensive Agents
  • Endothelin-1
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate
  • Epoprostenol